Literature DB >> 2302377

Anticonvulsant properties of propofol and thiopentone: comparison using two tests in laboratory mice.

S Lowson1, J P Gent, C S Goodchild.   

Abstract

Experiments were carried out in mice to assess the protection provided by thiopentone (Intraval, May and Baker) and propofol (Diprivan, I.C.I.) against epileptiform seizures induced by electroshock and pentylenetetrazol. Intraperitoneal administration of propofol 50 mg kg-1 and thiopentone 25 mg kg-1 produced similar peak behavioural effects of mild sedation and incoordination. However, at these doses propofol afforded a greater degree of protection against pentylenetetrazol than thiopentone and at greater doses both propofol and thiopentone caused marked protection. Both anaesthetics were effective also against electroshock seizures at sedative doses. We conclude that propofol has strong anticonvulsant properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302377     DOI: 10.1093/bja/64.1.59

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

Review 1.  Acute pancreatitis after single-dose exposure to propofol: a case report and review of literature.

Authors:  Qaiser Jawaid; Michael E Presti; Brent A Neuschwander-Tetri; Frank R Burton
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties.

Authors:  E Sanna; C Motzo; M Usala; M Serra; L Dazzi; E Maciocco; G Trapani; A Latrofa; G Liso; G Biggio
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  A new intravenous anesthetic agent: propofol.

Authors:  T Duke
Journal:  Can Vet J       Date:  1995-03       Impact factor: 1.008

4.  Propofol-related convulsions.

Authors:  J C Bevan
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

5.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

6.  Propofol in the management of refractory status epilepticus: a case report.

Authors:  A Borgeat; O H Wilder-Smith; P Jallon; P M Suter
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 7.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 8.  Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment.

Authors:  J M Klafta; J P Zacny; C J Young
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

9.  Convulsive thresholds in mice during the recovery phase from anaesthesia induced by propofol, thiopentone, methohexitone and etomidate.

Authors:  S Lowson; J P Gent; C S Goodchild
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 10.  Excitatory events associated with propofol anaesthesia: a review.

Authors:  J R Sneyd
Journal:  J R Soc Med       Date:  1992-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.